Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332826 · ClinicalTrials.gov registry record · Phase 3
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
A Phase 3 study, sponsored by Mannkind Corporation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT00332826: Clinical Trial Phase 3 study, sponsored by Mannkind Corporation.
NCT00332826 is a Phase 3 study that was terminated before completion, run by Mannkind Corporation. The registered enrollment target is 3 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00332826, a Phase 3 study, was terminated before completion, sponsored by Mannkind Corporation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.
Interventions
- DRUG Technosphere Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Why NCT00332826 stopped before completion
NCT00332826 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Technosphere Insulin is the first listed.
NCT00332826 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00332826 about?
NCT00332826 is a clinical study titled "Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma". The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.
What is the current status of trial NCT00332826?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2006-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00332826?
The interventions under investigation include: Technosphere Insulin (DRUG).
Who is sponsoring clinical trial NCT00332826?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00332826's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia